Who we are
ABOUT MEDICINES FOR EUROPE
PURPOSE AND OBJECTIVES
OUR VALUES – OUR 5 PILLARS
STRUCTURE
MEMBERS
BECOME A MEMBER
CODE OF CONDUCT
DISCLOSURE
Key topics
COVID-19
ACCESS
INDUSTRIAL POLICY
REGULATORY AND LEGAL FRAMEWORK
FALSIFIED MEDICINES
ENVIRONMENT
ANTIMICROBIAL RESISTANCE
MEDICINE SHORTAGES
Publications
EXTERNAL RESOURCES
FACTSHEETS
INFOGRAPHICS
PODCAST
POLICY
REPORTS
VIDEOS
Newsroom
IN THE NEWS
PRESS RELEASES
Contact us
Login
Generic medicines
Home
Medicines for Europe
Generic medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
Definition
THERAPEUTIC AREAS
GLOSSARY
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Related links
Contact us
Twitter
Biosimilar medicines
Home
Medicines for Europe
Biosimilar medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
DEFINITION
THERAPEUTIC AREAS
GLOSSARY
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
External resources
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Related links
Contact us
Twitter
Value added medicines
Home
Who we are
Value added medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
Definition
THERAPEUTIC AREAS
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Contact us
Events
Biosimilar Medicines, an Opportunity for Healthcare – Video with subtitles in 15 languages
6 November 2015
Biosimilar medicines, an opportunity for healthcare:
Biosimilar medicines, an opportunity for healthcare (EN subtitles):
Medicamentos biossimilares, uma oportunidade para a Saúde:
Médicaments biosimilaires, une opportunité pour les soins de santé:
Biosimilar-Arzneimittel, eine Chance für die Healthcare:
Medicamentele biosimilare – o oportunitate pentru asistenţa medicală:
Medicamentos biosimilares. Una oportunidad para el sistema de salud:
Leki biopodobne, szansa dla opieki zdrowotnej:
Biosimilární léciva. Príležitost pro zdravotnictví:
Farmaci biosimilari. Un’opportunità
per il settore sanitario:
Biosimilars: een kans voor de gezondheidszorg:
Biosimilære lægemidler.
En mulighed for lægevideskaben:
Biosimilarläkemedel. En möjlighet för sjukvården:
Medicamentos Biossimilares.
Uma oportunidade para a saúde:
Toplum sağlığı için bir fırsat:
Biyobenzer İlaçlar:
Related Posts
European patients need improved access to biosimilar…
22 April 2021
Fifteen years after the first global approval, biosimilar medicines systemically…
Billions more euros to re-invest in better healthcare thanks…
13 December 2022
Biosimilar medicines deliver access for patients suffering from serious and…
Spanish Presidency set to advance medicines supply…
4 July 2023
The EU pharmaceutical strategy aims to improve accessibility, affordability and…
All routes to healthcare efficiency include biosimilar…
9 December 2020
Medicines For Europe
Who we are
Key topics
Publications
Newsroom
Contact us
SECTOR GROUPS
Generic medicines
WHO WE ARE
DID YOU KNOW?
WHAT’S NEW
OUR 5 PILLARS
FIND OUT MORE
Biosimilar medicines
WHO WE ARE
DID YOU KNOW?
WHAT’S NEW
OUR 5 PILLARS
FIND OUT MORE
Value added medicines
WHO WE ARE
DID YOU KNOW?
WHAT’S NEW
OUR 5 PILLARS
Events
Tweet
Tweet
Tweet
LinkedIn